Vaginal Slings Market Research Report - Global Forecast till 2027

Global Vaginal Slings Market: Information By Type (Tension-Free Vaginal Tape Slings (TVT) and Others), By Method (Retropubic Method, Transobturator Method and others), By End User (Hospitals, Ambulatory Surgical Centers and others) - Forecast till 2027

ID: MRFR/HC/6416-CR | May 2019 | Region: Global | 103 pages

Please note that the assessment period of report has been updated from 2015-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview


Market Research Future (MRFR) confirms that the Vaginal Slings Market can reach USD 1,459 Million by 2023, as a result of the surge in researches in the urinary incontinence field to develop more effective treatment options.


COVID-19 Analysis


The COVID-19 outbreak has had a negative impact on the vaginal slings market, with the healthcare increasingly focusing on patients suffering from SARS-CoV-2. The novel coronavirus has however given a boot to telehealth and telemedicine, bolstering the communication between patients and healthcare workers. The overall economic downfall brought on by the pandemic has also affected the vaginal slings industry, but the latter can gain impetus once the lockdown is lifted across countries.


Market Dynamics


Drivers


Escalation in Urinary Incontinence Diseases to Benefit Market


Significant rise in the burden of urinary incontinence worldwide has been favorable for the global vaginal slings market. The Global Forum of Incontinence (GFI) reveals that in 2018, the urinary incontinence rate was greater among women compared to men. The same source also said that the prevalence of the disorder among the female base aged 20 and more, is nearly 12.4% and is close to 45% among women aged 40 and older. Most of these women face daily urinary incontinence as well as stress urinary incontinence, which should bolster the vaginal slings market share. The availability of supportive reimbursement schemes across countries offering vaginal sling surgeries at affordable costs will not only bring down the economic burden but also result in market expansion.


Soaring preference among patients for minimally invasive procedures could be some of the key vaginal slings market trends that will ensure significant growth in the coming years. Sensing the opportunity, firms are launching devices that facilitate minimally invasive treatment of urinary incontinence. Other than this, the burgeoning female elderly base and the growing risks of urinary incontinence could also enhance the market size


Opportunities


Technical Advances to Emerge as a Lucrative Opportunity


Backed by increased efforts by eminent firms in the form of rapid technological innovations in vaginal slings provides lucrative opportunities for market expansion. Moreover, rising advances with respect to the materials used for making advanced vaginal slings can also be a profitable opportunity in the global market.


Restraints


Availability of Alternative Treatment Options to be a Major Threat


One of the major restraints identified in the MRFR report is the growing inclination towards alternative treatments options available for urinary incontinence. Alternative treatment options include medications such as mirabegron, anticholinergic, topical estrogen and alpha blockers, along with various other products including transvaginal slings preferred by doctors for repairing damaged or weakened tissues in the bladder.


Challenges


Hesitance among Women to go for Surgeries to be a Huge Challenge


Reluctance among women to go for surgeries owing to complications that sometimes result from sub-urethral slings, including injury to bladder or urethra, bleeding, urethral mesh erosion, urinary tract infection (UTI) and more could be a big challenge for the top players.


Cumulative Growth Analysis


Global Market to Progress at a Decent Pace


MRFR believes that vaginal slings market size can burgeon at a rate of 3.6% from 2015 to 2023 (appraisal period), in view of stress urinary incontinence accounting for a considerable percentage of overall healthcare spending and the need to curb it.


Segment Overview


Tension-Free Vaginal Tape Slings to be the Most Preferred Type


The product type-based market segments are mini-slings or single incision slings, transobturator tape slings (TOT), tension-free vaginal tape slings (TVT), and others. Tension-free vaginal tape slings have gained high prevalence since it is safe and involve low invasiveness and fast completion of the procedure.


Transobturator Method to Secure the Leading Spot


The vaginal slings market, with respect to method, caters to transobturator method, single-incision mini method and retropubic method. The transobturator method should lead the global market, owing to the benefits of using this method over others, such as lower chances of bowel injury, blood vessel injury or bladder injury, ease of the technique, and efficacy similar to that of tension-free vaginal tape slings.


Hospital Segment to be the Leading End-User


The key end users considered in the report include urogynecology clinics, ambulatory surgical clinics, hospitals, and others. The hospitals segment can most likely take the lead and touch USD 539.7 Million by 2023.


Regional Analysis


America to Claim the Top Position


The American market is slated to claim the top position over the next few years, thanks to the robust presence of modern healthcare infrastructure, skilled medical professionals and frequent technological innovations. The mounting use of vaginal slings for treating stress urinary incontinence along with the strong presence of world-renowned firms in the region also add to the market value. The region is known for spending considerably on healthcare, which works in the favor of the market, while the high availability of innovative slings like vaginal mesh and vaginal mini slings also foster growth.  


Europe Exhibits Impressive Growth Potential


Europe shows high growth potential and primarily benefits from the significant budget allocated for healthcare in the region. In 2017, Germany owned a 27% share in the Western European vaginal slings industry, as a result of the surging incidences of stress urinary incontinence among the female population and the expanding female elderly population prone to urinary incontinence.


Asia Pacific to Advance at the Fastest Rate


The APAC market is all set to capture the fastest growth rate during the assessment period, with Japan emerging as the top performer. The Asia Pacific market can maintain a healthy growth rate throughout the review period, thanks to the surging burden of chronic diseases like urinary incontinence, especially among older women. Also, technological advances, increasing disposable income along with the rapid improvement in the healthcare industry can propel the vaginal slings market size in the region.


Competitive Landscape


Players Focus on Developing Nutritional Solutions with Added Features


Most of the firms that own substantial vaginal slings market share, are focused on competitive strategies such as merger, collaboration, acquisition, and others to gain a bigger share in the global market, while also trying to expand their product ranges. The vaginal slings industry is competitive to some extent, wherein players are adopting a few more strategies like product innovations and invention to foster their growth scope.


Coloplast Corp. is one of the top firms in the vaginal slings market, offering a wide range of treatment options, enabling patients and physicians to work together and understand the best actionable option depending on the medical situation. Coloplast also offers a number of educational programs that open up the communication scope between physicians in Gynecology, Urogynecology and Urology while bolstering their knowledge about urinary incontinence and pelvic floor prolapse as well as the advanced devices available.


List of Key Companies Covered in this Report



  • M.I. GmbH (Austria)

  • Boston Scientific Corporation (US)

  • Ethicon Inc. (US)

  • Coloplast Corp (Denmark)

  • CL Medical (France)

  • Betatech Medical (Istanbul)

  • Herniamesh S.r.l. (Italy)

  • Promedon (Argentina)


Recent Developments



  • April 2020 – A study has been carried out at 23 hospitals in Canada and the US to compare the efficacy as well as safety of the Altis Single-Incision Sling System developed by Coloplast with the general mid-urethral transobturator slings. The conclusion after a 12 months vigorous analysis says that Altis SIS’s efficacy and safety is quite similar to that of a standard transobturator midurethral vaginal sling.


Report Overview


MRFR experts have critically evaluated the vaginal slings market, considering the base year along with the review period as well as the value projected in the said period. The market study also comprises some of the key developments post the COVID-19 outbreak in the worldwide market. Besides, all the leading vendors and the top strategies adopted by them to remain competitive are also listed in the report.


Scope of the Report


The scope of the report covers the significance of vaginal slings and their use-cases. Urinary incontinence takes place due to issues in in either storing, emptying or filling the bladder, while in some cases, the combination of all these issues are also prevalent. The report segments the global vaginal slings market based on product type, by method, by end-user and by region.


Segmentation Table


Vaginal Slings Market, By Product Type



  • Tension-Free Vaginal Tape Slings (TVT)

  • Transobturator Tape Slings (TOT)

  • Mini-Slings/Single Incision Slings

  • Others


Vaginal Slings Market, By Method



  • Retropubic Method

  • Transobturator Method

  • Single-Incision Mini Method


Vaginal Slings Market, By End User



  • Hospitals

  • Ambulatory Surgery Centers

  • Urogynecology Clinics

  • Others



Frequently Asked Questions (FAQ) :


The vaginal slings market is projected to grow at a 3.6% CAGR between 2015-2023.

The Americas is expected to dominate the vaginal slings market.

The vaginal slings market is predicted to touch USD 1,459 million by 2023.

Rising prevalence of urinary incontinence is boosting market growth.

Complications during surgery may deter market growth.



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.